A MaassenVanDenBrink

Summary

Affiliation: Erasmus University
Country: The Netherlands

Publications

  1. ncbi request reprint Craniovascular selectivity of eletriptan and sumatriptan in human isolated blood vessels
    A MaassenVanDenBrink
    Department of Pharmacology, Erasmus University Medical Centre Rotterdam EMCR, The Netherlands
    Neurology 55:1524-30. 2000
  2. ncbi request reprint 5-HT1B receptor polymorphism and clinical response to sumatriptan
    A MaassenVanDenBrink
    Department of Pharmacology, Erasmus University Rotterdam, The Netherlands
    Headache 38:288-91. 1998

Detail Information

Publications2

  1. ncbi request reprint Craniovascular selectivity of eletriptan and sumatriptan in human isolated blood vessels
    A MaassenVanDenBrink
    Department of Pharmacology, Erasmus University Medical Centre Rotterdam EMCR, The Netherlands
    Neurology 55:1524-30. 2000
    ..Eletriptan is a 5-HT(1B/1D) receptor agonist with proven efficacy in the acute treatment of migraine...
  2. ncbi request reprint 5-HT1B receptor polymorphism and clinical response to sumatriptan
    A MaassenVanDenBrink
    Department of Pharmacology, Erasmus University Rotterdam, The Netherlands
    Headache 38:288-91. 1998
    ..74; C:0.26 at nt 861 and T:0.39; G:0.61 at nt -261) did not differ between patient groups, indicating that genetic diversity of the 5-HT1B receptor does not seem to be involved in the different clinical responses to sumatriptan...